Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
192.67
-1.53 (-0.79%)
May 1, 2026, 4:00 PM EDT - Market closed

Quest Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,0751,0469219081,0152,080
Depreciation & Amortization
724570493439437408
Stock-Based Compensation
868888777779
Other Adjustments
18213233-770-421
Change in Receivables
-185-106-71-1524681
Changes in Accounts Payable
170129-67-55-14935
Changes in Income Taxes Payable
222416-2-31-20
Changes in Other Operating Activities
-773-79-7353-9
Operating Cash Flow
1,8501,8861,3341,2721,7182,233
Operating Cash Flow Growth
23.83%41.38%4.87%-25.96%-23.06%11.37%
Capital Expenditures
-524-527-425-408-404-403
Payments for Business Acquisitions
-139-101-2,164-611-144-331
Proceeds from Business Divestments
-----755
Other Investing Activities
-5-341-425-
Investing Cash Flow
-668-631-2,548-1,061-54321
Long-Term Debt Issued
1954101,8462,592--
Long-Term Debt Repaid
-413-1,012-303-1,844-2-2
Net Long-Term Debt Issued (Repaid)
-218-6021,543748-2-2
Issuance of Common Stock
115797372123129
Repurchase of Common Stock
-300-450-151-275-1,408-2,199
Net Common Stock Issued (Repurchased)
-185-371-78-203-1,285-2,070
Common Dividends Paid
-357-353-331-314-305-309
Other Financing Activities
-69-62-50-71-140-159
Financing Cash Flow
-979-1,3881,084160-1,732-2,540
Effect of Exchange Rate Changes on Cash and Cash Equivalents
24-7---
Net Cash Flow
205-129-137371-557-286
Free Cash Flow
1,3261,3599098641,3141,830
Free Cash Flow Growth
-2.43%49.50%5.21%-34.25%-28.20%15.31%
FCF Margin
11.76%12.32%9.21%9.34%13.30%16.96%
Free Cash Flow Per Share
11.7912.038.047.6511.1414.30
Levered Free Cash Flow
1,1215892,3521,5038502,004
Unlevered Free Cash Flow
1,5471,396976.25892.261,0391,861
Updated Apr 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q